INBP
INTEGRATED BIOPHARMA INC
Key Financials
Gross Profit
$800000
↓ 85.6%
Revenue
$43.7M
↓ 6.9%
Net Income
$-2842000
↓ 451.7%
Operating Income
$-2705000
↓ 233.9%
Total Assets
$25.3M
↑ 1.8%
Total Liabilities
$7.7M
↑ 67.3%
EPS (Diluted)
$-0.09
↓ 400.0%
Shareholders' Equity
$17.7M
↓ 13.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 9/25/2026 | View on SEC |
| 10-K | 9/25/2026 | View on SEC |
| 8-K | 8/20/2026 | View on SEC |
| 8-K | 7/2/2026 | View on SEC |
| 4/A | 6/25/2026 | View on SEC |
| 4 | 6/25/2026 | View on SEC |
| 4 | 6/25/2026 | View on SEC |
| 4 | 6/25/2026 | View on SEC |
| 4 | 6/25/2026 | View on SEC |
| 8-K | 5/8/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | INBP |
| Company Name | INTEGRATED BIOPHARMA INC |
| CIK | 1016504 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0630 |
| State of Incorporation | DE |
| Phone | 9739260816 |